What does TMJ stand for?

TMJ stands for Temporomandibular Joint, which is the joint connecting the jawbone to the skull.

How big is the TMJ Disorders Market?

The global TMJ Disorders Market size was estimated at USD 0.57 Billion in 2023 and is expected to reach USD 1.14 Billion in 2033.

What is the TMJ Disorders Market growth?

The global TMJ Disorders Market is expected to grow at a compound annual growth rate of 7.1%. From 2024 To 2033

Who are the key companies/players in the TMJ Disorders Market?

Some of the key players in the TMJ Disorders Markets are Sun Pharmaceutical Industries Ltd, Abbott Laboratories Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Bayer International AG, Allergan Inc., Zydus Cada, Jubilant Life Sciences Limited, Novartis Intemational AG.

What is the significance of the TMJ Disorders market?

The TMJ Disorders market focuses on conditions affecting the temporomandibular joint, and it plays a crucial role in providing treatments and solutions for individuals experiencing such disorders.

Why is North America dominant in the TMJ Disorders market?

North America dominates the TMJ Disorders market due to a high prevalence of TMJ disorders, supported by a well-established healthcare infrastructure, favorable reimbursement policies, and a high level of awareness among healthcare professionals and patients.

What are the key treatment advancements in the TMJ Disorders market?

Advancements in both surgical and non-surgical interventions for TMJ disorders are significant, reflecting a commitment to addressing the complexity of these disorders and improving patient outcomes.

Global TMJ Disorders Market By Type (Myofacial Pain, Intemal Derangement, Arthritis) By Treatment(Medication, Therapies, Surgery) By End-User( Hospitals , Clinics, , Ambulatory Surgery Centers, Academic and Research Institutes) By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Dec 2023
Report ID: 73455
Number of Pages: 303
Format:

- 1.TMJ Disorders Market Introduction
  - 1.1.Definition
  - 1.2.Taxonomy
  - 1.3.Research Scope
- 2.Executive Summary
  - 2.1.Key Findings by Major Segments
  - 2.2.Top strategies by Major Players
- 3.Global TMJ Disorders Market Overview
  - 3.1.TMJ Disorders Market Dynamics
    
    3.1.1.Drivers
    
    3.1.2.Opportunities
    
    3.1.3.Restraints
    
    3.1.4.Challenges
  - 3.2.COVID-19 Impact Analysis
  - 3.3.COVID-19 Impact Analysis in Global TMJ Disorders Market
  - 3.4.PESTLE Analysis
  - 3.5.Opportunity Map Analysis
  - 3.6.PORTER'S Five Forces Analysis
  - 3.7.Market Competition Scenario Analysis
  - 3.8.Product Life Cycle Analysis
  - 3.9.Opportunity Orbits
  - 3.10.Manufacturer Intensity Map
  - 3.11.Major Companies sales by Value & Volume
- 4.Global TMJ Disorders Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2015-2031
  - 4.1.Global TMJ Disorders Market Analysis by Type: Introduction
  - 4.2.Market Size and Forecast by Region
  - 4.3.Myofascial Pain
  - 4.4.Internal Derangement (ID)
  - 4.5.Osteoarthritis
- 5.Global TMJ Disorders Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Treatment, 2015-2031
  - 5.1.Global TMJ Disorders Market Analysis by Treatment: Introduction
  - 5.2.Market Size and Forecast by Region
  - 5.3.Medication
  - 5.4.Therapies
  - 5.5.Surgical Treatment
- 6.Global TMJ Disorders Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by End-User, 2015-2031
  - 6.1.Global TMJ Disorders Market Analysis by End-User: Introduction
  - 6.2.Market Size and Forecast by Region
  - 6.3.Hospitals & Clinics
  - 6.4.Ambulatory Surgery Centers
  - 6.5.Academic Institutes
  - 6.6.Other End-Users
- 7.Global TMJ Disorders Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2015-2031
  - 7.1.North America
    
    7.1.1.North America TMJ Disorders Market: Regional Trend Analysis
    
    7.1.1.1.U.S.
    
    7.1.1.2.Canada
    
    7.1.1.3.Mexico
  - 7.2.1.Europe
    
    7.2.1.Europe TMJ Disorders Market: Regional Trend Analysis
    
    7.2.1.1.U.K.
    
    7.2.1.2.Germany
    
    7.2.1.3.France
    
    7.2.1.4.Spain
    
    7.2.1.5.Italy
    
    7.2.1.6.Russia
    
    7.2.1.7.Rest of Europe
  - 7.3.Asia-Pacific
    
    7.3.1.Asia-Pacific TMJ Disorders Market: Regional Trend Analysis
    
    7.3.1.1.China
    
    7.3.1.2.Japan
    
    7.3.1.3.South Korea
    
    7.3.1.4.India
    
    7.3.1.5.ASEAN
    
    7.3.1.6.Rest of Asia-Pacific
  - 7.4.Latin America
    
    7.4.1.Latin America TMJ Disorders Market: Regional Trend Analysis
    
    7.4.1.1.Brazil
    
    7.4.1.2.Argentina
    
    7.4.1.3.Rest of Latin America
  - 7.5.Middle East and Africa
    
    7.5.1.Middle East and Africa TMJ Disorders Market: Regional Trend Analysis
    
    7.5.1.1.GCC
    
    7.5.1.2.Israel
    
    7.5.1.3.South Africa
    
    7.5.1.4.Rest of MEA
- 8.Global TMJ Disorders Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 8.1.Market Share Analysis
  - 8.2.Company Profiles
  - 8.3.Abbott Laboratories
    
    8.3.1.Company Overview
    
    8.3.2.Financial Highlights
    
    8.3.3.Product Portfolio
    
    8.3.4.SWOT Analysis
    
    8.3.5.Key Strategies and Developments
  - 8.4.Sun Pharmaceutical Industries Ltd.
    
    8.4.1.Company Overview
    
    8.4.2.Financial Highlights
    
    8.4.3.Product Portfolio
    
    8.4.4.SWOT Analysis
    
    8.4.5.Key Strategies and Developments
  - 8.5.Bristol Myers Squibb
    
    8.5.1.Company Overview
    
    8.5.2.Financial Highlights
    
    8.5.3.Product Portfolio
    
    8.5.4.SWOT Analysis
    
    8.5.5.Key Strategies and Developments
  - 8.6.Teva Pharmaceutical Industries Ltd.
    
    8.6.1.Company Overview
    
    8.6.2.Financial Highlights
    
    8.6.3.Product Portfolio
    
    8.6.4.SWOT Analysis
    
    8.6.5.Key Strategies and Developments
  - 8.7.Allergan Inc.
    
    8.7.1.Company Overview
    
    8.7.2.Financial Highlights
    
    8.7.3.Product Portfolio
    
    8.7.4.SWOT Analysis
    
    8.7.5.Key Strategies and Developments
  - 8.8.Bayer AG
    
    8.8.1.Company Overview
    
    8.8.2.Financial Highlights
    
    8.8.3.Product Portfolio
    
    8.8.4.SWOT Analysis
    
    8.8.5.Key Strategies and Developments
  - 8.9.Cadila Healthcare Limited
    
    8.9.1.Company Overview
    
    8.9.2.Financial Highlights
    
    8.9.3.Product Portfolio
    
    8.9.4.SWOT Analysis
    
    8.9.5.Key Strategies and Developments
  - 8.10.Novartis International AG
    
    8.10.1.Company Overview
    
    8.10.2.Financial Highlights
    
    8.10.3.Product Portfolio
    
    8.10.4.SWOT Analysis
    
    8.10.5.Key Strategies and Developments
  - 8.11.Pfizer Inc.
    
    8.11.1.Company Overview
    
    8.11.2.Financial Highlights
    
    8.11.3.Product Portfolio
    
    8.11.4.SWOT Analysis
    
    8.11.5.Key Strategies and Developments
- 9.Assumptions and Acronyms
- 10.Research Methodology
- 11.Contact
- Sun Pharmaceutical Industries Ltd
- Abbott Laboratories Inc
- Teva Pharmaceutical Industries Ltd. Company Profile
- Bristol-Myers Squibb Company
- Bayer International AG
- Allergan Inc.
- Zydus Cada
- Jubilant Life Sciences Limited
- Novartis Intemational AG
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 73455
Published Date Dec 2023
Rating
- ★★★★★
  
  ★★★★★
- (117)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)